These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35217618)

  • 1. Kurarinone alleviated Parkinson's disease via stabilization of epoxyeicosatrienoic acids in animal model.
    Sun CP; Zhou JJ; Yu ZL; Huo XK; Zhang J; Morisseau C; Hammock BD; Ma XC
    Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35217618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease.
    Ren Q; Ma M; Yang J; Nonaka R; Yamaguchi A; Ishikawa KI; Kobayashi K; Murayama S; Hwang SH; Saiki S; Akamatsu W; Hattori N; Hammock BD; Hashimoto K
    Proc Natl Acad Sci U S A; 2018 Jun; 115(25):E5815-E5823. PubMed ID: 29735655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble Epoxide Hydrolase Deficiency or Inhibition Attenuates MPTP-Induced Parkinsonism.
    Qin X; Wu Q; Lin L; Sun A; Liu S; Li X; Cao X; Gao T; Luo P; Zhu X; Wang X
    Mol Neurobiol; 2015 Aug; 52(1):187-95. PubMed ID: 25128026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble Epoxide Hydrolase Inhibition Attenuates MPTP-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System: Involvement of α-Synuclein Aggregation and ER Stress.
    Huang HJ; Wang YT; Lin HC; Lee YH; Lin AM
    Mol Neurobiol; 2018 Jan; 55(1):138-144. PubMed ID: 28822080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson's Disease: A New Therapeutic Strategy.
    Pallàs M; Vázquez S; Sanfeliu C; Galdeano C; Griñán-Ferré C
    Biomolecules; 2020 May; 10(5):. PubMed ID: 32369955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage.
    Wu CH; Shyue SK; Hung TH; Wen S; Lin CC; Chang CF; Chen SF
    J Neuroinflammation; 2017 Nov; 14(1):230. PubMed ID: 29178914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsomal epoxide hydrolase deletion enhances tyrosine hydroxylase phosphorylation in mice after MPTP treatment.
    Liu M; Hunter R; Nguyen XV; Kim HC; Bing G
    J Neurosci Res; 2008 Sep; 86(12):2792-801. PubMed ID: 18500758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aflatoxin B
    Wang W; Wang Y; Wagner KM; Lee RD; Hwang SH; Morisseau C; Wulff H; Hammock BD
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for glia maturation factor dependent activation of mast cells and microglia in MPTP induced dopamine loss and behavioural deficits in mice.
    Selvakumar GP; Ahmed ME; Thangavel R; Kempuraj D; Dubova I; Raikwar SP; Zaheer S; Iyer SS; Zaheer A
    Brain Behav Immun; 2020 Jul; 87():429-443. PubMed ID: 31982500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of p38 pathway-dependent MPTP-induced dopaminergic neurodegeneration in estrogen receptor alpha knockout mice.
    Hwang CJ; Choi DY; Jung YY; Lee YJ; Yun JS; Oh KW; Han SB; Oh S; Park MH; Hong JT
    Horm Behav; 2016 Apr; 80():19-29. PubMed ID: 26836768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmed Death-1 Deficiency Aggravates Motor Dysfunction in MPTP Model of Parkinson's Disease by Inducing Microglial Activation and Neuroinflammation in Mice.
    Cheng YY; Chen BY; Bian GL; Ding YX; Chen LW
    Mol Neurobiol; 2022 Apr; 59(4):2642-2655. PubMed ID: 35142987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration.
    Lee E; Hwang I; Park S; Hong S; Hwang B; Cho Y; Son J; Yu JW
    Cell Death Differ; 2019 Jan; 26(2):213-228. PubMed ID: 29786072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.
    Liu Z; Qiu AW; Huang Y; Yang Y; Chen JN; Gu TT; Cao BB; Qiu YH; Peng YP
    Brain Behav Immun; 2019 Oct; 81():630-645. PubMed ID: 31351185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRPV4 contributes to ER stress and inflammation: implications for Parkinson's disease.
    Liu N; Bai L; Lu Z; Gu R; Zhao D; Yan F; Bai J
    J Neuroinflammation; 2022 Jan; 19(1):26. PubMed ID: 35093118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression Induced by Chronic Unpredictable Mild Stress Increases Susceptibility to Parkinson's Disease in Mice via Neuroinflammation Mediated by P2X7 Receptor.
    Ren C; Li LX; Dong AQ; Zhang YT; Hu H; Mao CJ; Wang F; Liu CF
    ACS Chem Neurosci; 2021 Apr; 12(7):1262-1272. PubMed ID: 33734697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    L'Episcopo F; Tirolo C; Caniglia S; Testa N; Serra PA; Impagnatiello F; Morale MC; Marchetti B
    J Neuroinflammation; 2010 Nov; 7():83. PubMed ID: 21092260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective role of 6-Hydroxy-1-H-Indazole in an MPTP-induced mouse model of Parkinson's disease.
    Xiao-Feng L; Wen-Ting Z; Yuan-Yuan X; Chong-Fa L; Lu Z; Jin-Jun R; Wen-Ya W
    Eur J Pharmacol; 2016 Nov; 791():348-354. PubMed ID: 27614126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teaghrelin protected dopaminergic neurons in MPTP-induced Parkinson's disease animal model by promoting PINK1/Parkin-mediated mitophagy and AMPK/SIRT1/PGC1-α-mediated mitochondrial biogenesis.
    Jhuo CF; Chen CJ; Tzen JTC; Chen WY
    Environ Toxicol; 2024 Jul; 39(7):4022-4034. PubMed ID: 38622810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
    Pariyar R; Bastola T; Lee DH; Seo J
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabidiol Alleviates the Damage to Dopaminergic Neurons in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinson's Disease Mice Via Regulating Neuronal Apoptosis and Neuroinflammation.
    Wang L; Wu X; Yang G; Hu N; Zhao Z; Zhao L; Li S
    Neuroscience; 2022 Aug; 498():64-72. PubMed ID: 35792194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.